期刊文献+

流式细胞仪同时检测实体肿瘤P53蛋白和DNA含量 被引量:2

Simultaneous analysis of P53 expression and DNA content in solid cancer using flow cytometry
下载PDF
导出
摘要 目的 :建立流式细胞仪检测方法 ,研究P5 3抑癌基因蛋白与DNA的关系。方法 :71例肿瘤手术样本 ,其中良性 8例 ,恶性 6 3例。①用机械方法获得实体肿瘤组织的单细胞悬液 ,1%多聚甲醛固定 ,或 5 0 %— 95 %乙醇固定 ,0 1%tritonX 10 0处理。先P5 3 FITC核抗原标记 ,再溴化丙啶 (PI)染DNA ,流式细胞仪双参数分析。②相同样本 32例P5 3蛋白免疫组化ABC法检测。结果 :1%多聚甲醛固定方法优于酒精固定法。流式细胞仪分析结果与免疫组化一致 (Kappa>0 0 4)。P5 3过量表达与DNA倍体相关 (P <0 0 0 5 )。结论 :流式细胞仪双参数检测DNA含量和癌基因蛋白是一个快速 。 Purpose:To study the relationship of P53 suppressor oncongene protein and DNA content in cancer cell and establish a simultaneous analysis of P53 expression and DNA contant by flow cytometry. Methods:We have studied the P53 protein in conjunction with DNA content in solid samples from 71 patients with tumor using flow cytometry. The suspension were obtained by mechanical disaggregation followed by a short fixation in 1% paraformadehyde. Immunohistochemical results obtained with the same monoclone antibody in the same 32 samples. Results:Paraformaldehyde fixed cells exhibited significantly greater positive ratio than ethanol fixed cells. The flow cytometric value correlated with immunohistochemical results. (Kappa>0 04). P53 over expression was significantly associated with DNA content ( P <0 005).Conclusions:Flow cytometry could be a feasible technique for clinical detection.
出处 《中国癌症杂志》 CAS CSCD 2000年第2期101-103,共3页 China Oncology
关键词 P53蛋白 DNA含量 流式细胞仪 肿瘤 P53 protein DNA conten paraformaldehyde fixed flow cytometry cancer
  • 相关文献

参考文献4

  • 1[1]Agrawal RS, Agrawal YP, Mantyjarvi RA. Flow cytometric quantation of c-myc and P53 protein in boving papillomavirus type 1-transformed primary mous fibroblasta[J]. Cytometry,1994,17(3):237-245.
  • 2[2]Kim Steck, Adel K, EL-Naggar. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms[J]. Cytometry, 1994,17(3):258-265.
  • 3[3]Kim steck , Timothy J.MCDonnel, Adel K.EL-Naggar. Flow cytomtric analysis of apoptosis and bcl-2 in human solid neoplasms[J]. Cytometry,1995,20(2):154-161.
  • 4[4]Olle stal,Siw Sullivan,Sun XF, et al. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry[J].Cytometry,1994,16(2):160-168.

同被引文献26

  • 1李莉,祝峙,方国恩,施俊义,盛援.COX-2和p53在乳腺癌组织中的表达及其相关性[J].中华肿瘤防治杂志,2006,13(4):287-289. 被引量:10
  • 2安莉,王静,俞森洋.COX-2和p53蛋白在非小细胞肺癌中的表达及与微血管生成的相关性研究[J].中国肿瘤临床与康复,2007,14(1):1-4. 被引量:10
  • 3Lane D P, Crawford L V. T antigen is bound to a host protein in SV40-transformed cells[J]. Nature, 197,278(5701):261- 263.
  • 4Day A, Verma C S, Lane D P. Modulation of p53 degradation as a therapeutic approach[J]. Cancer, 2008,98(1):4-8.
  • 5Murray Zmijewski F, Lane D P, Bourdon J C, et al. p53/p63/ p 73 isoforms: an orchestra of isoforms:an orchestra of isoforms to harmonise cell differentiation and response to stress [J]. Cell Death Differ, 2006,13(6):962-972.
  • 6Wirtenberger M, Frank B, Hemminki K, et al. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer[J]. Carcinogenesis, 2006,27:1655-1660.
  • 7Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities[J]. Cell Death Differ, 2006,13(6): 951-961.
  • 8Zhu W G, Hileman T, Ke Y, et al. 5-aza2-deoxycytidine activities the p53/p21 "",1(,,1'1 pathway to inhibit cell proliferation [J]. J Biol Chem, 2004,279(15):15161-15166.
  • 9Moreira I S, Fernandes P A, Ramos M J. Protein-protein recognition: a computational mutagenesis study of the MDM2- P53 complex[J]. Theor Chern Account, 2008,120(1):533-542.
  • 10Svane J M, Pedersen A E, Nikolaisen K, et al. Aiterations inp53- specific T cells and other I ymphocyte subsets in breast cancer patients during vaccination with p53- peptide loaded dendritic cells and low-dose interleukin-2[J]. Vaccine, 2008.26(36):4716-4724.

引证文献2

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部